| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| gsk3 inhibitor clinical trial | 0.88 | 1 | 7852 | 74 | 29 |
| gsk3 | 1.63 | 0.1 | 5643 | 2 | 4 |
| inhibitor | 0.18 | 0.5 | 454 | 13 | 9 |
| clinical | 0.41 | 0.9 | 2507 | 10 | 8 |
| trial | 1.57 | 0.7 | 5851 | 27 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| gsk3 inhibitor clinical trial | 0.17 | 1 | 8743 | 43 |
| gsk-3 inhibitor | 1.08 | 0.1 | 3122 | 98 |
| gsk-3 inhibitor 3 | 0.26 | 0.6 | 4531 | 53 |
| gsk-3 inhibitor bio | 0.39 | 0.7 | 8887 | 95 |
| gsk 3 beta inhibitor | 1.57 | 0.5 | 5479 | 61 |
| gsk-3-inhibitor-ii | 0.64 | 0.5 | 7395 | 3 |
| gsk 3 inhibitor ix | 0.87 | 0.5 | 4304 | 88 |
| gsk clinical trial register | 0.89 | 0.1 | 9207 | 10 |
| gsk clinical trials uk | 0.36 | 0.7 | 1087 | 7 |
| rsk inhibitor clinical trial | 0.83 | 0.4 | 1819 | 59 |
| skp2 inhibitor clinical trial | 1.81 | 0.1 | 4210 | 79 |
| gsk oncology clinical trials | 1.04 | 0.8 | 7306 | 91 |
| sgk1 inhibitor in clinical trial | 0.24 | 0.5 | 754 | 92 |
| how to inhibit gsk3b | 0.78 | 0.1 | 4082 | 84 |
| gsk3-in-3 | 1.47 | 0.4 | 3104 | 87 |
| gsk clinical trials cambridge | 1.82 | 0.5 | 3925 | 18 |
| what does gsk3 do | 0.31 | 0.1 | 826 | 62 |
| gsk3-like kinase | 1.5 | 0.3 | 2854 | 9 |
| gsk3-beta | 1.04 | 0.2 | 9065 | 70 |
| anti-gsk3 beta therapeutic potential | 0.32 | 0.6 | 9491 | 60 |
| anti-gsk3 beta role in cancer | 1.58 | 0.9 | 6829 | 19 |
